Newsletter | June 2, 2025

06.02.25 -- Master The Final Critical Step In Drug Manufacturing

21st Century Manufacturing Of Injectable Pharmaceuticals

Pharmaceutical and biotech companies are under mounting pressure to accelerate timelines and be the first to reach the clinic or market. Discover how rising competition, niche patient populations, and evolving therapies are reshaping sterile injectable drug development with cutting-edge technologies.

 

How Robotic Isolator Technology Aligns To Annex 1 Principles

The standards for pharmaceutical manufacturing are constantly rising. Explore how robotic gloveless isolators provide exceptional automation to eliminate human intervention, reduce contamination risk, and ensure compliance with the EU Annex 1 guideline, which enhances sterility, precision, and monitoring.

 

CDMO Uses Robotic Gloveless Isolator For Advanced Therapeutics

Developing and manufacturing biologics can be complex, which means CDMOs must innovate production architectures to meet the demands of advanced therapeutics to ensure a reliable supply and compliance. Uncover how these approaches advance modern medicine and improve patient outcomes.

 

A Shift Towards Biofluorescent Particle Counters In Manufacturing

Sterility in injectable drug manufacturing is vital, which not only safeguards patient health but also plays a pivotal role in enhancing manufacturing efficiency. Find out how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.

 

SOLUTIONS

Solutions To Help You Gain Speed To Clinic And Market

See how speed, cost, and regulatory acceptance impact drug manufacturing, as well as learn about aseptic filling challenges and how innovative services can enhance your efficiency and compliance.

• Request Information